CPMDCannapharmarx Inc.

About Cannapharmarx Inc. (CPMD)

Cannapharmarx Inc. (CPMD) is a Drug Manufacturers - Specialty & Generic company headquartered in Calgary, AB, Canada whose shares trade over-the-counter on the Pink tier.

CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. Cannabinoids are a class of chemicals that, once ingested, are active in humans and animals through the "endocannabinoid system" -- one of the most widely expressed system of receptors in the human body. CannaPharmaRx is currently focused on targeting disease states where its delivery systems can have optimal impact with therapeutic differentiation among alternative cannabinoid therapies, including: neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders and ophthalmology.

CPMD key facts

Ticker symbol

CPMD

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Calgary, AB, Canada

Country of incorporation

US

Year of incorporation

2014

Employees

9

Estimated market cap

$3.63M (as of Apr 11, 2025)

Shares outstanding

660,626,405

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Cannapharmarx Inc. leadership

• John Cassels — CFO, Secretary
• Andrew Steedman — EVP, COO
• Nicholas F Coscia — Securities Counsel

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with C